Anti-smoking vaccine on trial
Jul 19 - Swedish scientists begin human trials on a shot intended to stop nicotine reaching the brain.
The experts behind the vaccine say it will eliminate the nicotine highs that smokers relish and therefore help tobacco addicts to quit but some have their doubts it will be that simple.
Paul Chapman reports.
No videos currently selected.
Click 
on any video below, from any channel, to add it to your playlist.
Philippines massacre toll rises
Featured Videos
Reuters.com:
Help and Contact Us |
Advertise With Us |
Mobile |
Newsletters |
RSS
|
Labs |
Journalism Handbook |
Archive |
Site Index |
Video Index
Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers
International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
